Related Experiment Video
Updated: Jun 29, 2025

07:02
An Assay for Quantifying Protein-RNA Binding in Bacteria
Published on: June 12, 2019
6.6K
Structural basis of Acinetobacter type IV pili targeting by an RNA virus
Ran Meng1,2, Zhongliang Xing1, Jeng-Yih Chang1,3
1Center for Phage Technology, Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Nature Communications
|March 30, 2024
Summary
Acinetobacter phage AP205 binds to bacterial type IV pili. Researchers developed a novel protein scaffold targeting these pili for potential research and diagnostics.
Area of Science:
- Microbiology
- Structural Biology
- Virology
Background:
- Acinetobacter species are significant human pathogens, particularly in immunocompromised individuals.
- Type IV pili are key virulence factors in Acinetobacter, contributing to antibiotic resistance.
- Bacterial viruses (bacteriophages) can target bacterial pili.
Purpose of the Study:
- To investigate the structural basis of the interaction between Acinetobacter phage AP205 and type IV pili.
- To characterize the structural adaptations of the phage and pili during binding.
- To engineer a novel protein-based tool for targeting type IV pili.
Main Methods:
- Cryo-electron microscopy (cryo-EM) was used to determine high-resolution structures.
- Structural analysis of the phage virion, native type IV pili, and the pili-phage complex.
- Protein engineering to develop a phage-derived scaffold.
Main Results:
- The structure of Acinetobacter phage AP205 bound to type IV pili was solved.
- Distinct post-translational modifications of native Acinetobacter type IV pili were identified.
- The phage's maturation proteins were observed to adapt to pilin modifications for binding.
- A 20-kilodalton protein scaffold derived from AP205 was successfully developed.
Conclusions:
- The study reveals the molecular mechanism of Acinetobacter phage AP205 binding to type IV pili.
- The identified pilin modifications and phage adaptations provide insights into host-pathogen interactions.
- The engineered AP205-derived protein scaffold shows promise as a research and diagnostic tool targeting bacterial type IV pili.
More Related Videos
Related Concept Videos
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
Viral Structure
62.2K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
62.2K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Intracellular Movement of Viruses and Bacteria
2.8K
Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a...
2.8K
Bacterial RNA Polymerase
29.5K
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
29.5K

